|
|
Acura Pharmaceuticals, Inc. (Inactive Symbol) |
YTD Price Probability |
No random walk data for 2024
|
Default Prediction for 2016-12-31 |
Default prediction by Z-Score (what's this?).
View the other companies in the same industry : N/A
Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):
For manufacuring companies:
Sector Industry |
For non-manufacturing companies:
Sector Industry
|
|
Fundamental Analysis for 2017 |
Fundamental Analysis metrics & ratios (what's this?).
Date of financial statements used: 2017-03-31 |
Book Value: |
$340.0K |
|
Internal Value: |
$340.0K |
|
Working Capital: |
$2.3M |
Debt to Asset Ratio: |
0.806 |
|
Current Ratio: |
1.532 |
|
Turnover Ratio: |
14.387 |
Net Margin: |
15.1% |
|
EPS: |
0.138 |
|
P/E ratio: |
3.837 |
P/B ratio: |
18.500 |
|
ROE: |
482.4% |
|
ROA: |
18.5% |
|
|
Company ProfileSymbol: ACUR Market Cap: $6.3M Exchange: NASDAQ Sector: N/A Industry: N/A Data Since: 1993-01-04 Website: acurapharm.com [Web Query] [News Query]
|